DK2303268T3 - Farmaceutiske sammensætninger baseret på kinin-B2-receptorantagonister og corticosteroider og anvendelser deraf - Google Patents

Farmaceutiske sammensætninger baseret på kinin-B2-receptorantagonister og corticosteroider og anvendelser deraf

Info

Publication number
DK2303268T3
DK2303268T3 DK09793880.7T DK09793880T DK2303268T3 DK 2303268 T3 DK2303268 T3 DK 2303268T3 DK 09793880 T DK09793880 T DK 09793880T DK 2303268 T3 DK2303268 T3 DK 2303268T3
Authority
DK
Denmark
Prior art keywords
quinine
corticosteroids
pharmaceutical compositions
receptor antagonists
compositions based
Prior art date
Application number
DK09793880.7T
Other languages
English (en)
Inventor
Sandro Giuliani
Carlo Alberto Maggi
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Application granted granted Critical
Publication of DK2303268T3 publication Critical patent/DK2303268T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK09793880.7T 2008-07-11 2009-07-03 Farmaceutiske sammensætninger baseret på kinin-B2-receptorantagonister og corticosteroider og anvendelser deraf DK2303268T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2008A001264A IT1391236B1 (it) 2008-07-11 2008-07-11 Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso
PCT/EP2009/004847 WO2010003601A1 (en) 2008-07-11 2009-07-03 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use

Publications (1)

Publication Number Publication Date
DK2303268T3 true DK2303268T3 (da) 2012-07-23

Family

ID=40466843

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09793880.7T DK2303268T3 (da) 2008-07-11 2009-07-03 Farmaceutiske sammensætninger baseret på kinin-B2-receptorantagonister og corticosteroider og anvendelser deraf

Country Status (36)

Country Link
US (1) US8476276B2 (da)
EP (1) EP2303268B1 (da)
JP (1) JP5791501B2 (da)
KR (1) KR101656324B1 (da)
CN (1) CN102088975B (da)
AP (1) AP2803A (da)
AR (1) AR072734A1 (da)
AU (1) AU2009267416B2 (da)
BR (1) BRPI0915866A2 (da)
CA (1) CA2730420A1 (da)
CO (1) CO6341556A2 (da)
CR (1) CR20110021A (da)
CY (1) CY1112900T1 (da)
DK (1) DK2303268T3 (da)
EA (1) EA019903B1 (da)
EC (1) ECSP11010752A (da)
ES (1) ES2389872T3 (da)
GE (1) GEP20135792B (da)
HK (1) HK1158547A1 (da)
HN (1) HN2011000089A (da)
HR (1) HRP20120678T1 (da)
IL (1) IL210554A0 (da)
IT (1) IT1391236B1 (da)
MA (1) MA32542B1 (da)
MX (1) MX2011000350A (da)
MY (1) MY150477A (da)
NI (1) NI201100014A (da)
NZ (1) NZ590427A (da)
PL (1) PL2303268T3 (da)
PT (1) PT2303268E (da)
RS (1) RS52418B (da)
SI (1) SI2303268T1 (da)
TW (1) TWI499419B (da)
UA (1) UA100060C2 (da)
WO (1) WO2010003601A1 (da)
ZA (1) ZA201100287B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120190653A1 (en) * 2011-01-20 2012-07-26 Dow Pharmaceutical Sciences, Inc. Therapeutic eye drop comprising doxycycline and a stabilizer
JP2016514141A (ja) * 2013-03-14 2016-05-19 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド Ｂ２−ブラジキニン受容体媒介の血管浮腫の治療方法
CN104072585A (zh) * 2014-07-21 2014-10-01 成都圣诺生物科技股份有限公司 一种合成艾替班特的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1412360A4 (en) * 2001-06-26 2004-07-07 Metaphore Pharmaceuticals Inc COMBINATION THERAPY WITH A SODM AND A CORTICOSTEROID FOR THE PREVENTION AND / OR TREATMENT OF FLAMMABLE DISEASES
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
DE10304994A1 (de) * 2003-02-07 2004-09-02 Aventis Pharma Deutschland Gmbh Die Verwendung von Antagonisten des Bradykinin-B2 Rezeptors zur Behandlung von Osteoarthrose
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
EP1741444A1 (en) * 2005-07-05 2007-01-10 Jerini AG Kinin antagonists for treating bladder dysfunction
EP1894559A1 (en) * 2006-09-01 2008-03-05 PARI Pharma GmbH Means to solubilise steroids for inhalation

Also Published As

Publication number Publication date
ECSP11010752A (es) 2011-04-29
NI201100014A (es) 2011-09-13
EA019903B1 (ru) 2014-07-30
EA201100013A1 (ru) 2011-08-30
SI2303268T1 (sl) 2012-10-30
BRPI0915866A2 (pt) 2015-11-03
ZA201100287B (en) 2012-03-28
GEP20135792B (en) 2013-03-25
JP5791501B2 (ja) 2015-10-07
TWI499419B (zh) 2015-09-11
IT1391236B1 (it) 2011-12-01
IL210554A0 (en) 2011-03-31
EP2303268A1 (en) 2011-04-06
MA32542B1 (fr) 2011-08-01
UA100060C2 (uk) 2012-11-12
AU2009267416A1 (en) 2010-01-14
CY1112900T1 (el) 2016-04-13
CN102088975B (zh) 2013-08-21
CO6341556A2 (es) 2011-11-21
CA2730420A1 (en) 2010-01-14
HN2011000089A (es) 2013-01-28
KR20110044970A (ko) 2011-05-03
MY150477A (en) 2014-01-30
TW201006471A (en) 2010-02-16
US20110112011A1 (en) 2011-05-12
US8476276B2 (en) 2013-07-02
WO2010003601A1 (en) 2010-01-14
ITMI20081264A1 (it) 2010-01-12
CR20110021A (es) 2011-07-11
AP2803A (en) 2013-11-30
KR101656324B1 (ko) 2016-09-09
NZ590427A (en) 2012-09-28
AR072734A1 (es) 2010-09-15
RS52418B (en) 2013-02-28
CN102088975A (zh) 2011-06-08
JP2011527296A (ja) 2011-10-27
MX2011000350A (es) 2011-02-22
ES2389872T3 (es) 2012-11-02
WO2010003601A8 (en) 2010-03-18
HRP20120678T1 (hr) 2012-09-30
PT2303268E (pt) 2012-09-24
HK1158547A1 (en) 2012-07-20
EP2303268B1 (en) 2012-06-20
AU2009267416B2 (en) 2013-09-12
PL2303268T3 (pl) 2012-11-30
AP2011005572A0 (en) 2011-02-28

Similar Documents

Publication Publication Date Title
LTC2140867I2 (lt) Farmacinė kompozicija
DK3345625T3 (da) Farmaceutisk sammensætning og indgivelser deraf
BRPI0721651A2 (pt) Composição farmacêutica
BRPI0924137A2 (pt) composição farmacêutica sólida compreendendo amlodipina e losartan com melhor estabilidade
DK2081951T3 (da) Progesteron-receptorantagonister
RU2493831C3 (ru) Фармацевтические композиции
BRPI0923836A2 (pt) Composições farmacêuticas orais contendo opióide e métodos
DK2214679T3 (da) Kortikosteroidsammensætninger
BRPI0715712A2 (pt) Composição farmacêutica
BRPI0919539A2 (pt) antagonistas de receptor de opioide periférico e empregos dos mesmos
DK2154966T3 (da) Benzimidazoler og farmaceutiske sammensætninger deraf
BRPI0719393A2 (pt) Composição farmacêutica
BRPI0809931A2 (pt) Antagonistas do receptor do hormônio liberador de gonadotrofina e métodos relacionados com o mesmo
DK2120884T3 (da) Farmaceutisk sammensætning
DK2139890T3 (da) Perifere opioidreceptor-antagonister og anvendelser deraf
BRPI0716445A2 (pt) composiÇço farmacÊutica
LTPA2018508I1 (lt) Anti-FGF23 antikūnas ir jį apimanti farmacinė kompozicija
DK2285413T3 (da) Farmaceutisk sammensætning
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
BRPI0921654A2 (pt) formulação farmacêutica
DK2285357T3 (da) Farmaceutisk sammensætning omfattende brivaracetam
BRPI0921313A2 (pt) composição farmaucêutica
BRPI0817833A2 (pt) Composição farmacêutica antimalárica
BRPI0820198A2 (pt) composições farmacêuticas
DK2391351T3 (da) Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater